These are known to be upregulated on tumour cells in response to pro-inflammatory cytokines such as interferon γ (IFN-γ) and tumour necrosis factor α (TNF-α), while co-stimulatory molecules including CD80 and CD86 are downregulated [16,17,18]. The gene discussed is IFNG; the disease is neoplasm.